Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 1 |
2024 | 1 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Metabolome and transcriptome integration reveals metabolic profile of hepatocellular carcinoma.
J Gastroenterol Hepatol. 2022 Dec;37(12):2321-2330. doi: 10.1111/jgh.16024. Epub 2022 Nov 1.
J Gastroenterol Hepatol. 2022.
PMID: 36208127
MT1JP-mediated miR-24-3p/BCL2L2 axis promotes Lenvatinib resistance in hepatocellular carcinoma cells by inhibiting apoptosis.
Yu T, Yu J, Lu L, Zhang Y, Zhou Y, Zhou Y, Huang F, Sun L, Guo Z, Hou G, Dong Z, Wang B.
Yu T, et al.
Cell Oncol (Dordr). 2021 Aug;44(4):821-834. doi: 10.1007/s13402-021-00605-0. Epub 2021 May 11.
Cell Oncol (Dordr). 2021.
PMID: 33974236
Free PMC article.
Item in Clipboard
IL-17a promotes hepatocellular carcinoma by increasing FAP expression in hepatic stellate cells via activation of the STAT3 signaling pathway.
Sun D, Li W, Ding D, Tan K, Ding W, Wang Z, Fu S, Hou G, Zhou WP, Gu F.
Sun D, et al.
Cell Death Discov. 2024 May 13;10(1):230. doi: 10.1038/s41420-024-01995-4.
Cell Death Discov. 2024.
PMID: 38740736
Free PMC article.
Item in Clipboard
Cite
Cite